Germany · Delayed Price · Currency is EUR Abbott Laboratories Statistics
Total Valuation
ETR:ABL has a market cap or net worth of EUR 185.72 billion. The enterprise value is 191.41 billion.
| Market Cap | 185.72B |
| Enterprise Value | 191.41B |
Important Dates
The last earnings date was Wednesday, July 16, 2025.
| Earnings Date | Jul 16, 2025 |
| Ex-Dividend Date | Jul 15, 2025 |
Share Statistics
| Current Share Class | 1.74B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.07% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.73B |
Valuation Ratios
The trailing PE ratio is 15.66 and the forward PE ratio is 23.00.
| PE Ratio | 15.66 |
| Forward PE | 23.00 |
| PS Ratio | 5.06 |
| PB Ratio | 4.45 |
| P/TBV Ratio | 11.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 16.14 |
| EV / Sales | 5.23 |
| EV / EBITDA | 19.31 |
| EV / EBIT | 27.55 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.14 |
| Debt / FCF | n/a |
| Interest Coverage | 15.17 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 8.76% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 321,994 |
| Profits Per Employee | 104,032 |
| Employee Count | 114,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5.18B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.56% in the last 52 weeks. The beta is 0.74, so ETR:ABL's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +10.56% |
| 50-Day Moving Average | 114.55 |
| 200-Day Moving Average | 115.01 |
| Relative Strength Index (RSI) | 39.43 |
| Average Volume (20 Days) | 554 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.85 |
Income Statement
In the last 12 months, ETR:ABL had revenue of EUR 36.71 billion and earned 11.86 billion in profits. Earnings per share was 6.79.
| Revenue | 36.71B |
| Gross Profit | 20.62B |
| Operating Income | 6.96B |
| Pretax Income | 6.73B |
| Net Income | 11.86B |
| EBITDA | 9.62B |
| EBIT | 6.96B |
| Earnings Per Share (EPS) | 6.79 |
Balance Sheet
The company has 5.83 billion in cash and 11.32 billion in debt, giving a net cash position of -5.49 billion.
| Cash & Cash Equivalents | 5.83B |
| Total Debt | 11.32B |
| Net Cash | -5.49B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 41.78B |
| Book Value Per Share | 23.89 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 56.17%, with operating and profit margins of 18.97% and 32.43%.
| Gross Margin | 56.17% |
| Operating Margin | 18.97% |
| Pretax Margin | 18.32% |
| Profit Margin | 32.43% |
| EBITDA Margin | 26.21% |
| EBIT Margin | 18.97% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.10, which amounts to a dividend yield of 1.96%.
| Dividend Per Share | 2.10 |
| Dividend Yield | 1.96% |
| Dividend Growth (YoY) | 5.08% |
| Years of Dividend Growth | 6 |
| Payout Ratio | n/a |
| Buyback Yield | 0.07% |
| Shareholder Yield | 2.02% |
| Earnings Yield | 6.39% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |